P7 A New Polyisobutylene Based Thermoplastic Elastomer

Wednesday, October 10, 2012
East Concourse-2nd Flr (Duke Energy Center)
Attila Gergely, Polymer science, The University of Akron, Akron, OH and Judit Puskas, Chemical and Biomolecular Engineering, Polymer Science, The University of Akron, Akron, OH
A new polyisobutylene based thermoplastic elsatomer has been developed by the copolymerization of Alloocimene with Isobutylene. The resulting copolymer has a chain structure with diblock character, where the soft part is the polyisobutylene portion and the hard segment is the polyalloocimene portion.1Despite of the diblock character the material exhibits thermoplastic elastomeric properties, with close to 6MPa tensile strength and 1000 % strain at break. The polymer also exhibits strong filler interaction.

Isobutylene has been used as the soft segments of thermoplastic elastomers prior2, however in each case the structure of the polymer was either triblock3 or brached2. The former composition has been used to develop the coating of the coronary stent3, whereas the latter material is currently under investigation for breast implant material replacement.

Thus the presented thermoplastic elastomer has a potential to be used for a wide range of application ranging from commercial rubber product to biomaterial for biomedical devices and implants.

References

 

(1)

Puskas, J.E.; Kaszas, G.; Gergely, A.L. US Patent Application # 61/587,736. January, 2011.

(2)

Puskas, J. E.; Dos Santos, L. M.; Kaszas, G. ; Kulbaba, K. J. Polym. Sci., Part A: Polym. Chem., 2009,  47(4),  1148-1158.

(3)

Kennedy, J. P., Kaszas, G., Puskas, J. E., Hager, W. G. U.S. 4,946,899. 1990. FDA Approval for drug-eluting coronary stent application (to Boston Scientific Co., 2004); in commercial production (Kaneka Inc., BASF AG)